![]() |
市场调查报告书
商品编码
1812095
一次性泵浦市场-全球产业规模、份额、趋势、机会和预测(按材料、应用、灭菌、地区和竞争细分,2020-2030 年)Single-Use Pump Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented, By Material, By Application, By Sterilization, By Region & Competition, 2020-2030F |
2024年,一次性泵浦市场规模为12.7亿美元,预计到2030年将达到26.7亿美元,复合年增长率为12.99%。一次性泵浦市场涵盖一次性或一次性使用泵浦的开发、製造和部署,主要应用于生物製药、医疗保健和生命科学产业,但其应用范围正逐渐扩展到食品饮料、化学和工业领域。一次性泵浦的设计旨在安全高效地输送流体,无需清洁、灭菌或防止批次间交叉污染,在营运效率、成本降低和法规遵循方面具有显着优势。
市场概况 | |
---|---|
预测期 | 2026-2030 |
2024年市场规模 | 12.7亿美元 |
2030年市场规模 | 26.7亿美元 |
2025-2030年复合年增长率 | 12.99% |
成长最快的领域 | 聚乙烯 |
最大的市场 | 北美洲 |
这些系统通常包括蠕动泵、隔膜泵和气动泵等,它们与一次性导管、组件和一次性流体路径相容,可快速设定并最大限度地减少生产和研究过程中的停机时间。市场受到对生物製药製造解决方案日益增长的需求的推动,尤其是在单株抗体、疫苗以及细胞和基因疗法领域,在这些领域中,中小批量生产的污染预防和灵活性至关重要。越来越多的製药和生技公司正在采用一次性技术,以加快药物开发进度,减少与不銹钢系统相关的资本支出,并提高整体生产的可扩展性。
此外,一次性泵浦支援模组化和灵活的製造架构,这对于合约製造组织 (CMO) 以及生产个人化药物或小批量生物製剂的工厂尤其重要,因为传统的固定式不銹钢基础设施在这些领域可能不经济。除了医疗保健领域,一次性泵浦在食品和饮料加工、化妆品製造和化学品生产领域也越来越受欢迎,因为製造商正在寻求高效的流体处理解决方案,以减少清洁要求、防止跨批次污染并支持法规遵循。泵浦材料、管道技术和感测器整合方面的进步也使市场受益,这些进步提高了精度、可靠性和监控能力,同时扩大了可处理的流体和黏度范围。
生物製药和生命科学製造业需求不断成长
初始成本高,投资障碍多
生物製药製造业的日益普及
The Single-Use Pump Market was valued at USD 1.27 Billion in 2024 and is expected to reach USD 2.67 Billion by 2030 with a CAGR of 12.99%. The Single-Use Pump Market encompasses the development, manufacturing, and deployment of pumps designed for disposable or single-use applications, primarily within the biopharmaceutical, healthcare, and life sciences industries, although adoption is gradually expanding into food and beverage, chemical, and industrial sectors. Single-use pumps are engineered to transfer fluids safely and efficiently without the need for cleaning, sterilization, or cross-contamination prevention between batches, offering significant advantages in terms of operational efficiency, cost reduction, and regulatory compliance.
Market Overview | |
---|---|
Forecast Period | 2026-2030 |
Market Size 2024 | USD 1.27 Billion |
Market Size 2030 | USD 2.67 Billion |
CAGR 2025-2030 | 12.99% |
Fastest Growing Segment | Polyethylene |
Largest Market | North America |
These systems typically include peristaltic, diaphragm, and pneumatic-driven pumps, among others, that are compatible with single-use tubing, assemblies, and disposable fluid paths, enabling rapid setup and minimizing downtime in production and research processes. The market is driven by the growing demand for biopharmaceutical manufacturing solutions, particularly in monoclonal antibodies, vaccines, and cell and gene therapies, where contamination prevention and flexibility in small-to-medium batch production are critical. Increasingly, pharmaceutical and biotechnology companies are adopting single-use technologies to accelerate drug development timelines, reduce capital expenditures associated with stainless-steel systems, and enhance overall production scalability.
Furthermore, single-use pumps support modular and flexible manufacturing architectures, which are particularly relevant for contract manufacturing organizations (CMOs) and facilities producing personalized medicines or small-volume biologics, where traditional fixed stainless-steel infrastructure may be economically unfeasible. Beyond healthcare, single-use pumps are gaining traction in food and beverage processing, cosmetic manufacturing, and chemical production, as manufacturers seek efficient fluid handling solutions that reduce cleaning requirements, prevent cross-batch contamination, and support regulatory compliance. The market also benefits from advancements in pump materials, tubing technologies, and sensor integration, which improve precision, reliability, and monitoring capabilities while expanding the range of fluids and viscosities that can be handled.
Key Market Drivers
Rising Demand in Biopharmaceutical and Life Sciences Manufacturing
The global biopharmaceutical industry is witnessing unprecedented growth, driven by increasing prevalence of chronic diseases, rising investments in biotechnology research, and an expanding pipeline of biologics and vaccines. Single-use pumps have emerged as a critical component in modern biopharmaceutical manufacturing due to their ability to streamline production processes, reduce contamination risks, and enhance operational efficiency. Unlike traditional stainless-steel systems, single-use pumps eliminate the need for extensive cleaning and sterilization procedures, significantly reducing downtime and overall manufacturing costs.
The growing adoption of biologics, including monoclonal antibodies, cell therapies, and recombinant proteins, has intensified the need for flexible and reliable fluid handling solutions that can accommodate varying batch sizes and complex production workflows. Additionally, regulatory compliance in life sciences manufacturing demands stringent contamination control, which single-use technologies inherently support by minimizing the risk of cross-contamination and microbial ingress. The integration of these pumps into upstream and downstream processes, such as media transfer, formulation, and buffer preparation, enables manufacturers to achieve higher productivity while maintaining product integrity.
This trend is particularly pronounced in contract manufacturing organizations (CMOs) and research institutions, which increasingly rely on modular, disposable systems to accelerate time-to-market for new therapies. Furthermore, the global expansion of biopharmaceutical manufacturing facilities, especially in emerging markets across Asia-Pacific and Latin America, is driving large-scale adoption of single-use pumps, as manufacturers seek cost-effective, scalable solutions to meet growing demand. The ability to deploy single-use systems quickly and with minimal infrastructure investment aligns with the industry's broader push toward flexible, adaptive manufacturing models that can respond rapidly to shifting market needs.
This driver is expected to remain a key growth catalyst, as ongoing innovation in pump designs, including enhanced flow control, automated monitoring, and compatibility with a wider range of fluids, continues to expand their applicability across diverse biopharmaceutical processes. Overall, the convergence of increasing biologics production, stringent regulatory requirements, and the need for operational efficiency is establishing single-use pumps as a cornerstone technology in modern life sciences manufacturing, ensuring sustained market expansion over the coming years. More than 9,000 biopharmaceutical manufacturing facilities are operating worldwide to meet rising therapeutic and vaccine demand. Over 1,200 monoclonal antibody therapies are currently in development across global pipelines. Around 60% of global clinical trials are linked to biopharmaceutical innovations in oncology, neurology, and rare diseases. The global workforce in biopharma and life sciences manufacturing exceeds 1.8 million professionals. Over 300 cell and gene therapy products are in late-stage development globally. Approximately 40% of new drug approvals annually come from biopharmaceuticals.
Key Market Challenges
High Initial Costs and Investment Barriers
One of the most significant challenges facing the single-use pump market is the high initial cost associated with adoption, which can limit accessibility, especially for small to mid-sized biotechnology firms and contract manufacturing organizations (CMOs). Unlike traditional stainless-steel systems, single-use pumps and associated components require specialized materials, including medical-grade plastics, polymers, and precision-engineered fittings, which drive up procurement costs. Additionally, companies must often invest in complementary infrastructure, such as disposable tubing, connectors, and sensors, to ensure seamless integration into existing production workflows.
This initial financial outlay can be a substantial barrier, particularly in emerging markets where funding and capital availability are constrained, thereby slowing market penetration despite clear long-term operational benefits. Beyond purchase costs, companies also face expenses related to training and technical skill development, as operators and engineers must be proficient in handling single-use systems to avoid contamination risks and ensure optimal performance. Moreover, organizations may incur costs from waste management and regulatory compliance, since disposable components must be handled in accordance with environmental and safety regulations.
This combination of upfront capital expenditure, recurring operational costs, and regulatory considerations makes adoption a carefully weighed decision, leading some companies to delay transition from traditional systems. Consequently, manufacturers of single-use pumps are challenged to balance pricing strategies with innovation, ensuring products remain cost-effective while meeting stringent quality and performance standards. This scenario is particularly critical in regions with price-sensitive markets, where the higher cost of single-use pumps compared to reusable systems can result in slower uptake.
Addressing this challenge requires strategic collaboration between suppliers, end-users, and industry stakeholders, potentially through financing solutions, modular systems, or scalable options that reduce initial expenditure while highlighting the long-term efficiency, contamination reduction, and productivity gains of single-use systems. Overall, while the high initial cost represents a clear barrier to widespread adoption, it also underscores the need for manufacturers to continuously innovate, optimize production efficiency, and provide value propositions that clearly demonstrate return on investment over the product lifecycle, thereby driving broader market acceptance.
Key Market Trends
Growing Adoption in Biopharmaceutical Manufacturing
The Single-Use Pump Market is witnessing a significant uptrend driven by the growing adoption of single-use technologies across biopharmaceutical manufacturing, where flexibility, sterility, and operational efficiency are paramount. Traditional stainless-steel systems require extensive cleaning and validation, leading to increased production downtime and higher operational costs. In contrast, single-use pumps offer sterile, disposable fluid handling solutions that streamline processes, reduce cross-contamination risks, and enhance overall manufacturing productivity. This trend is further reinforced by the rapid expansion of biologics, vaccines, and cell and gene therapy production, which demand highly flexible, small-batch, and multi-product manufacturing environments.
Manufacturers are increasingly deploying single-use pumps to accommodate these needs, enabling faster process changeovers and reducing the reliance on cleaning validation protocols. Additionally, the growing complexity of biopharmaceutical formulations, including sensitive proteins and living cells, requires precise, low-shear fluid handling that single-use pumps can reliably deliver. Companies are also leveraging integrated single-use systems combining pumps, tubing, and sensors to provide end-to-end process control, improving batch consistency and ensuring regulatory compliance.
The global push for personalized medicines and accelerated drug development timelines has further amplified the demand for modular, scalable solutions, reinforcing the role of single-use pumps in enhancing manufacturing agility. This trend is particularly pronounced in regions such as North America and Europe, where the biopharma sector is highly mature, while emerging markets in Asia-Pacific are beginning to adopt single-use systems as part of their modernization initiatives.
With increasing regulatory support for flexible manufacturing technologies and the ongoing shift toward contract manufacturing organizations (CMOs), the biopharmaceutical segment is poised to remain a dominant driver of single-use pump adoption, contributing to sustained market growth over the next decade. Overall, the alignment of single-use pump solutions with the evolving needs of advanced therapeutics, cost efficiency, and operational flexibility underscores a robust and transformative trend in biopharmaceutical manufacturing.
In this report, the Global Single-Use Pump Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies presents in the Global Single-Use Pump Market.
Global Single-Use Pump Market report with the given Market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report: